title: Heart failure: Aldosterone antagonism for HFpEF.
authors.forename: Barry A
authors.initials: BA
authors.lastname: Borlaug
mesh_terms: D015415:Biomarkers / Q000097:blood; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D054144:Heart Failure, Diastolic / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D013148:Spironolactone / Q000627:therapeutic use*; D013318:Stroke Volume; D016896:Treatment Outcome; D020257:Ventricular Remodeling / Q000187:drug effects
chemical_list: D015415:Biomarkers; D002317:Cardiovascular Agents; D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone
references.citation: Am Heart J. 2011 Dec;162(6):966-972.e10
references.pmid: 22137068
references.citation: Eur J Heart Fail. 2013 Jul;15(7):776-85
references.pmid: 23426022
references.citation: Eur Heart J. 2011 Mar;32(6):670-9
references.pmid: 21138935
references.citation: J Am Coll Cardiol. 2010 Sep 7;56(11):845-54
references.pmid: 20813282
references.citation: Circulation. 2004 Aug 3;110(5):558-65
references.pmid: 15277317
references.citation: JAMA. 2013 Feb 27;309(8):781-91
references.pmid: 23443441
references.citation: Circ Heart Fail. 2008 Nov;1(4):227-33
references.pmid: 19808296
references.citation: N Engl J Med. 2006 Jul 20;355(3):251-9
references.pmid: 16855265
references.citation: Lancet. 2007 Jun 23;369(9579):2079-87
references.pmid: 17586303
references.citation: Circulation. 2003 Oct 14;108(15):1831-8
references.pmid: 14517164